Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Perspective Therapeutics, Inc.ISR · Entity 694 | Director · CEO and Chairman of the Board | March 01, 2018 | March 02, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Perspective Therapeutics, Inc.
Report date March 01, 2018 · Filed March 02, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 316,333 |
Ending reported balance
After 2018-03-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-03-01 · Purchase · Acquired 4,186 · Balance 270,519 Row 2 · 2018-03-01 · Purchase · Acquired 45,814 · Balance 316,333 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2018 Filed Mar 2, 2018 21:05 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | PurchaseCommon Stock | 45,814 | $0.44 | $20,158.16 |
DisclosureSEC source: 0001437749-18-003788 · rdgdoc.xml · nonDerivative · entry 2 LAVOY THOMAS C · CIK 0001067569 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,333 Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 21:05 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | PurchaseCommon Stock | 4,186 | $0.43 | $1,799.98 |
DisclosureSEC source: 0001437749-18-003788 · rdgdoc.xml · nonDerivative · entry 1 LAVOY THOMAS C · CIK 0001067569 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,519 Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 21:09 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionStock Options (right to buy) · Derivative | 82,810 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001437749-17-019680 · rdgdoc.xml · derivative · entry 2 LAVOY THOMAS C · CIK 0001067569 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 632,190 Underlying: Common Stock · 82,810 shares Expires 2027-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: 715,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested. The shares exercised on 11/20/2017 represent a portion of the shares that vested on 6/27/2017. F1 · shares: 715,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested. The shares exercised on 11/20/2017 represent a portion of the shares that vested on 6/27/2017. F1 · derivative.exercise_date: 715,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested. The shares exercised on 11/20/2017 represent a portion of the shares that vested on 6/27/2017. F1 · derivative.underlying_shares: 715,000 stock options were granted on 6/27/2017. 25% vested on 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested. The shares exercised on 11/20/2017 represent a portion of the shares that vested on 6/27/2017. Read SEC document |
| November 20, 2017 Filed Nov 21, 2017 21:09 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Exercise / conversionCommon Stock | 82,810 | $0.61 | $50,100.05 |
DisclosureSEC source: 0001437749-17-019680 · rdgdoc.xml · nonDerivative · entry 1 LAVOY THOMAS C · CIK 0001067569 · Director · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2017 Filed Jun 30, 2017 00:57 UTC Amendment | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 715,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001642247-17-000015 · primary_doc.xml · derivative · entry 3 LAVOY THOMAS C · CIK 0001067569 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 715,000 shares Expires 2027-06-27 F1 · security: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. F2 · derivative.exercise_date: 25% vested as of 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 21:02 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | GrantStock Options (right to buy) · Derivative | 715,000 | $0.00 Strike: $0.61 | $0.00 |
DisclosureSEC source: 0001642247-17-000009 · primary_doc.xml · derivative · entry 3 LAVOY THOMAS C · CIK 0001067569 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 715,000 shares Expires 2027-06-27 F1 · security: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. F2 · derivative.exercise_date: 25% vested as of 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested. Read SEC document |
| June 15, 2017 Filed Jun 30, 2017 00:57 UTC Amendment | Perspective Therapeutics, Inc. ISR · Entity 694 | Disposition to issuerStock Options (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001642247-17-000015 · primary_doc.xml · derivative · entry 2 LAVOY THOMAS C · CIK 0001067569 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2026-06-21 F1 · security: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. F1 · derivative.exercise_date: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. Read SEC document |
| June 15, 2017 Filed Jun 30, 2017 00:57 UTC Amendment | Perspective Therapeutics, Inc. ISR · Entity 694 | Disposition to issuerStock Options (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0001642247-17-000015 · primary_doc.xml · derivative · entry 1 LAVOY THOMAS C · CIK 0001067569 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2026-02-15 F1 · security: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. F1 · derivative.exercise_date: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. Read SEC document |
| June 15, 2017 Filed Jun 29, 2017 21:02 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Disposition to issuerStock Options (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001642247-17-000009 · primary_doc.xml · derivative · entry 2 LAVOY THOMAS C · CIK 0001067569 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2026-06-21 F1 · security: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. F1 · derivative.exercise_date: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. Read SEC document |
| June 15, 2017 Filed Jun 29, 2017 21:02 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | Disposition to issuerStock Options (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0001642247-17-000009 · primary_doc.xml · derivative · entry 1 LAVOY THOMAS C · CIK 0001067569 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2026-02-15 F1 · security: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. F1 · derivative.exercise_date: The three reported transactions involved a termination of outstanding options, resulting in the deemed cancellation of the old options and the grant of a new option. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 23:11 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | PurchaseCommon Stock | 20,000 | $0.53 | $10,600.00 |
DisclosureSEC source: 0001642247-17-000004 · primary_doc.xml · nonDerivative · entry 1 LAVOY THOMAS C · CIK 0001067569 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,523 Read SEC document |
| November 17, 2016 Filed Nov 22, 2016 01:30 UTC | Perspective Therapeutics, Inc. ISR · Entity 694 | PurchaseCommon stock | 20,000 | $0.60 | $12,000.00 |
DisclosureSEC source: 0001642247-16-000010 · primary_doc.xml · nonDerivative · entry 1 LAVOY THOMAS C · CIK 0001067569 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,523 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.